Top advances of the year: Acute myeloid leukemia

This article highlights key advances in the treatment of acute myeloid leukemia, specifically menin inhibitors for relapsed disease and retinoic acid/arsenic-based therapy for high-risk acute promyel…

Read the full article here

Related Articles